Feasibility of alcohol screening among patients receiving opioid treatment in primary care

BMC Family Practice

Research Article

Rolande Anderson¹  Eamon Keenan²  Tom P. O’Toole³  Anne Marie Henihan⁴  Clodagh O’Gorman⁴  Dorothy Leahy⁴  David Meagher⁴  Colum P. Dunne⁴  Jean Saunders⁵  Geoff McCombe⁶  Davina Swan⁷  Jan Klimas⁸  Walter Cullen⁹  Eileen Kaner^1,10  Gillian W. Shorter^1,11  Bobby P. Smyth^1,12  John S. Lambert^1,13  Gerard Bury^1,13 

[1] Addiction Counsellor, Suite 33, The Morrison Chambers, 32, Nassau Street, Dublin 2, Ireland;Addiction Services, Health Services Executive, Dublin, Ireland;Brown-Alpert Medical School, Providence, Rhode Island, USA;Department of Veterans’ Affairs, Washington DC, USA;Graduate Entry Medical School, Faculty of Education & Health Sciences, University of Limerick, Limerick, Ireland;Graduate Entry Medical School, Faculty of Education & Health Sciences, University of Limerick, Limerick, Ireland;CSTAR Centre, University of Limerick (UL), Limerick, Ireland;Graduate Entry Medical School, Faculty of Education & Health Sciences, University of Limerick, Limerick, Ireland;UCD School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland;Graduate Entry Medical School, Faculty of Education & Health Sciences, University of Limerick, Limerick, Ireland;UCD School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland;Addictions Department, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, 4 Windsor Walk, Denmark Hill, SE5 8BB, London, UK;Graduate Entry Medical School, Faculty of Education & Health Sciences, University of Limerick, Limerick, Ireland;UCD School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland;British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, 608-1081 Burrard Street, V6Z 1Y6, Vancouver, BC, Canada;Graduate Entry Medical School, Faculty of Education & Health Sciences, University of Limerick, Limerick, Ireland;UCD School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland;Department of Veterans’ Affairs, Washington DC, USA;Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK;Trinity Centre for Practice and Healthcare Innovation, School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland;Trinity Centre for Practice and Healthcare Innovation, School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland;Department of Public Health and Primary Care, Trinity College Dublin, Dublin, Ireland;UCD School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland;

关键词: Alcohol;    Primary care;    Screening;    Agonist treatment;    Methadone;    General practice;    Implementation;    Feasibility;    Brief intervention;    SBIRT;   

DOI  :  10.1186/s12875-016-0548-2

 received in 2016-02-24, accepted in 2016-10-21,  发布年份 2016

来源: Springer

【 摘 要 】

BackgroundIdentifying and treating problem alcohol use among people who also use illicit drugs is a challenge. Primary care is well placed to address this challenge but there are several barriers which may prevent this occurring. The objective of this study was to determine if a complex intervention designed to support screening and brief intervention for problem alcohol use among people receiving opioid agonist treatment is feasible and acceptable to healthcare providers and their patients in a primary care setting.MethodsA randomised, controlled, pre-and-post design measured feasibility and acceptability of alcohol screening based on recruitment and retention rates among patients and practices. Efficacy was measured by screening and brief intervention rates and the proportion of patients with problem alcohol use.ResultsOf 149 practices that were invited, 19 (12.8 %) agreed to participate. At follow up, 13 (81.3 %) practices with 81 (62.8 %) patients were retained. Alcohol screening rates in the intervention group were higher at follow up than in the control group (53 % versus 26 %) as were brief intervention rates (47 % versus 19 %). Four (18 %) people reduced their problem drinking (measured by AUDIT-C), compared to two (7 %) in the control group.ConclusionsAlcohol screening among people receiving opioid agonist treatment in primary care seems feasible. A definitive trial is needed. Such a trial would require over sampling and greater support for participating practices to allow for challenges in recruitment of patients and practices.

【 授权许可】

CC BY   
© The Author(s). 2016